{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:55:48Z","timestamp":1783475748958,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIA"},{"name":"Principal Investigators"},{"name":"Intramural Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.neurobiolaging.2013.05.028","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T06:15:30Z","timestamp":1374041730000},"page":"2696.e1-2696.e5","source":"Crossref","is-referenced-by-count":31,"title":["Alzheimer's disease risk genes and the age-at-onset phenotype"],"prefix":"10.1016","volume":"34","author":[{"given":"Madhav","family":"Thambisetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000332017","article-title":"Impact of SORL1 single nucleotide polymorphisms on Alzheimer's disease cerebrospinal fluid markers","volume":"32","author":"Alexopoulos","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib3","first-page":"270","article-title":"The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database","volume":"18","author":"Beekly","year":"2004","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ajmg.b.32094","article-title":"Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease","volume":"159B","author":"Bekris","year":"2012","journal-title":"Am. J. Med. Genet B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J.\u00a0R. Stat. Soc. Ser B"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","article-title":"ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative","volume":"48","author":"Blacker","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1750-1326-6-54","article-title":"Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study","volume":"6","author":"Carrasquillo","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","article-title":"GWAS of cerebrospinal fluid tau levels identified risk variants for Alzheimer's disease","volume":"78","author":"Cruchaga","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/302276","article-title":"Multipoint oligogenic analysis of age-at-onset data with applications to Alzheimer disease pedigrees","volume":"64","author":"Daw","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/302710","article-title":"The number of trait loci in late-onset Alzheimer disease","volume":"66","author":"Daw","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ajmg.b.30689","article-title":"A\u00a0genomic scan for age at onset of Alzheimer's disease in 437 families from the NIMH Genetic Initiative","volume":"147B","author":"Dickson","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib13","first-page":"24","article-title":"The Alzheimer's Association national policy agenda","volume":"66","author":"Duffy","year":"2005","journal-title":"N.\u00a0C. Med. J."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1037\/0033-2909.113.1.44","article-title":"Memory for the time of past events","volume":"113","author":"Friedman","year":"1993","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib15","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/mp.2010.123","article-title":"Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease","volume":"16","author":"Furney","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2377-10-90","article-title":"Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study","volume":"10","author":"Han","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajmg.b.30114","article-title":"Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease","volume":"135B","author":"Holmans","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib20","doi-asserted-by":"crossref","first-page":"e16616","DOI":"10.1371\/journal.pone.0016616","article-title":"Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease","volume":"6","author":"Hu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2013.03.018","article-title":"Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome","author":"Jones","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib22","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","article-title":"Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes","volume":"67","author":"Jun","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib23","doi-asserted-by":"crossref","first-page":"e15918","DOI":"10.1371\/journal.pone.0015918","article-title":"Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease","volume":"6","author":"Kauwe","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","article-title":"Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort","volume":"76","author":"Kim","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib25","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/339815","article-title":"Age at onset in two common neurodegenerative diseases is genetically controlled","volume":"70","author":"Li","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib27","doi-asserted-by":"crossref","first-page":"1518.e9","DOI":"10.1016\/j.neurobiolaging.2012.09.020","article-title":"Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative","volume":"34","author":"Meda","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","article-title":"The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers","volume":"20","author":"Morris","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrd3842","article-title":"Sting of Alzheimer's failures offset by upcoming prevention trials","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib31","doi-asserted-by":"crossref","first-page":"e6501","DOI":"10.1371\/journal.pone.0006501","article-title":"Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease","volume":"4","author":"Potkin","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib32","doi-asserted-by":"crossref","first-page":"e1311","DOI":"10.1016\/j.neurobiolaging.2012.08.014","article-title":"Exploratory analysis of seven Alzheimer's disease genes: disease progression","volume":"34","author":"Ruiz","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1469-1809.2012.00727.x","article-title":"Identification and confirmation of an exonic splicing enhancer variation in exon 5 of the Alzheimer disease associated PICALM gene","volume":"76","author":"Schnetz-Boutaud","year":"2012","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archneur.1995.00540250103019","article-title":"The age at onset of Alzheimer's disease and an intracranial area measurement. A relationship","volume":"52","author":"Schofield","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib35","doi-asserted-by":"crossref","first-page":"e44252","DOI":"10.1371\/journal.pone.0044252","article-title":"The PICALM protein plays a key role in iron homeostasis and cell proliferation","volume":"7","author":"Scotland","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib36","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/cns.12119","article-title":"Association between EXOC3L2 rs597668 polymorphism and Alzheimer's disease","author":"Shang","year":"2013","journal-title":"CNS Neurosci. Ther"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.55.7.964","article-title":"Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study","volume":"55","author":"Slooter","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib39","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1176\/appi.ajp.2012.11121815","article-title":"Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study","volume":"169","author":"Sweet","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WAD.0b013e318191c7dd","article-title":"The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery","volume":"23","author":"Weintraub","year":"2009","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.05.028_bib41","doi-asserted-by":"crossref","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","article-title":"Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis","volume":"287","author":"Xiao","year":"2012","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013002418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013002418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T21:13:53Z","timestamp":1715721233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013002418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0197458013002418"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.05.028","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}